Tinea pedis: an updated review.
Trichophyton interdigitale
Trichophyton rubrum
athlete’s foot
dermatophytosis
interdigital
moccasin
vesiculobullous
Journal
Drugs in context
ISSN: 1745-1981
Titre abrégé: Drugs Context
Pays: England
ID NLM: 101262187
Informations de publication
Date de publication:
2023
2023
Historique:
received:
06
05
2023
accepted:
02
06
2023
medline:
7
7
2023
pubmed:
7
7
2023
entrez:
7
7
2023
Statut:
epublish
Résumé
Tinea pedis is one of the most common superficial fungal infections of the skin, with various clinical manifestations. This review aims to familiarize physicians with the clinical features, diagnosis and management of tinea pedis. A search was conducted in April 2023 in PubMed Clinical Queries using the key terms 'tinea pedis' OR 'athlete's foot'. The search strategy included all clinical trials, observational studies and reviews published in English within the past 10 years. Tinea pedis is most often caused by Topical antifungal therapy (once to twice daily for 1-6 weeks) is the mainstay of treatment for superficial or localized tinea pedis. Examples of topical antifungal agents include allylamines (e.g. terbinafine), azoles (e.g. ketoconazole), benzylamine, ciclopirox, tolnaftate and amorolfine. Oral antifungal agents used for the treatment of tinea pedis include terbinafine, itraconazole and fluconazole. Combined therapy with topical and oral antifungals may increase the cure rate. The prognosis is good with appropriate antifungal treatment. Untreated, the lesions may persist and progress.
Sections du résumé
Background
UNASSIGNED
Tinea pedis is one of the most common superficial fungal infections of the skin, with various clinical manifestations. This review aims to familiarize physicians with the clinical features, diagnosis and management of tinea pedis.
Methods
UNASSIGNED
A search was conducted in April 2023 in PubMed Clinical Queries using the key terms 'tinea pedis' OR 'athlete's foot'. The search strategy included all clinical trials, observational studies and reviews published in English within the past 10 years.
Results
UNASSIGNED
Tinea pedis is most often caused by
Conclusion
UNASSIGNED
Topical antifungal therapy (once to twice daily for 1-6 weeks) is the mainstay of treatment for superficial or localized tinea pedis. Examples of topical antifungal agents include allylamines (e.g. terbinafine), azoles (e.g. ketoconazole), benzylamine, ciclopirox, tolnaftate and amorolfine. Oral antifungal agents used for the treatment of tinea pedis include terbinafine, itraconazole and fluconazole. Combined therapy with topical and oral antifungals may increase the cure rate. The prognosis is good with appropriate antifungal treatment. Untreated, the lesions may persist and progress.
Identifiants
pubmed: 37415917
doi: 10.7573/dic.2023-5-1
pii: dic-2023-5-1
pmc: PMC10321471
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Informations de copyright
Copyright © 2023 Leung AKC, Barankin B, Lam JM, Leong KF, Hon KL.
Déclaration de conflit d'intérêts
Disclosure and potential conflicts of interest: AKCL and KLH are associate editors of Drugs in Context and confirm that this article has no other conflicts of interest otherwise. This manuscript was sent out for independent peer review. The International Committee of Medical Journal Editors (ICMJE) Potential Conflicts of Interests form for the authors is available for download at: https://www.drugsincontext.com/wp-content/uploads/2023/06/dic.2023-5-1-COI.pdf
Références
J Dermatolog Treat. 2022 Feb;33(1):121-130
pubmed: 32043906
PLoS One. 2021 Aug 11;16(8):e0255932
pubmed: 34379681
Phytother Res. 2016 Mar;30(3):439-46
pubmed: 26666462
Dermatol Clin. 2003 Jul;21(3):431-62
pubmed: 12956197
J Ethnopharmacol. 2016 Sep 15;191:372-378
pubmed: 27340103
J Dtsch Dermatol Ges. 2014 Sep;12(9):749-77
pubmed: 25176455
J Am Acad Dermatol. 2022 Nov;87(5):e183-e184
pubmed: 35810839
Mycoses. 2023 Jan;66(1):29-34
pubmed: 35997514
Clin Exp Dermatol. 2010 Jul;35(5):468-72
pubmed: 19874338
J Drugs Dermatol. 2016 Feb 1;16(2):105-109
pubmed: 28300851
Curr Probl Pediatr Adolesc Health Care. 2018 Jan;48(1):3-25
pubmed: 29198783
Nat Prod Res. 2017 Feb;31(4):460-464
pubmed: 27309978
J Am Podiatr Med Assoc. 1988 May;78(5):250-3
pubmed: 3290435
Int J Dermatol. 2008 May;47(5):485-92
pubmed: 18412868
J Am Podiatr Med Assoc. 2015 Sep;105(5):407-11
pubmed: 26429609
Pediatr Clin North Am. 2014 Apr;61(2):443-55
pubmed: 24636655
Mycopathologia. 2017 Feb;182(1-2):127-141
pubmed: 27502503
J Dermatol. 2020 Jun;47(6):615-621
pubmed: 32293052
J Pediatr. 2015 Nov;167(5):1165
pubmed: 26316369
J Drugs Dermatol. 2015 Oct;14(10):1138-44
pubmed: 26461826
Jpn J Infect Dis. 2018 Nov 22;71(6):462-466
pubmed: 30175735
Acta Dermatovenerol Croat. 2014;22(3):175-9
pubmed: 25230057
Cutis. 2017 Aug;100(2):110-114
pubmed: 28961287
J Mycol Med. 2016 Dec;26(4):312-316
pubmed: 27184614
Med Clin North Am. 2014 Mar;98(2):213-25
pubmed: 24559870
Expert Opin Investig Drugs. 2018 Aug;27(8):637-647
pubmed: 30058384
Eur J Dermatol. 2015 Nov-Dec;25(6):570-7
pubmed: 26574949
Am Fam Physician. 2014 Nov 15;90(10):702-10
pubmed: 25403034
Curr Med Mycol. 2017 Dec;3(4):6-14
pubmed: 29707673
Intern Emerg Med. 2020 Sep;15(6):1107-1108
pubmed: 32200518
Clin Drug Investig. 2014 Mar;34(3):223-30
pubmed: 24477462
Mycopathologia. 2016 Jun;181(5-6):387-95
pubmed: 26883512
AAPS PharmSciTech. 2022 Jul 19;23(6):199
pubmed: 35854184
Med Mycol. 2010 May;48(3):476-9
pubmed: 19886762
Dermatol Online J. 2020 Jul 15;26(7):
pubmed: 32898398
Med Mycol Case Rep. 2016 Feb 22;11:13-5
pubmed: 26958461
Int J Sports Med. 2021 Dec;42(14):1297-1304
pubmed: 33975368
Int J Clin Pharmacol Ther. 2018 Jan;56(1):31-33
pubmed: 29191265
Infect Disord Drug Targets. 2021;21(3):384-388
pubmed: 32634085
J Mycol Med. 2015 Jun;25(2):116-22
pubmed: 25835157
J Am Podiatr Med Assoc. 2012 Jul-Aug;102(4):309-13
pubmed: 22826329
Can Fam Physician. 2021 Jan;67(1):30
pubmed: 33483393
J Drugs Dermatol. 2014 Apr;13(4):391-5; quiz 396
pubmed: 24719057
Am Fam Physician. 2008 May 15;77(10):1415-20
pubmed: 18533375
Drug Deliv Transl Res. 2016 Feb;6(1):38-47
pubmed: 26542152
Int J STD AIDS. 2022 Mar;33(3):296-303
pubmed: 34965797
Pak J Med Sci. 2016 Jul-Aug;32(4):891-5
pubmed: 27648034
Int J Dermatol. 1997 Sep;36(9):658-60
pubmed: 9352405
J Fungi (Basel). 2022 May 23;8(5):
pubmed: 35628801
MSMR. 2017 May;24(5):19-21
pubmed: 28570090
J Dermatolog Treat. 2021 Nov;32(7):783-787
pubmed: 31865826
Skin Appendage Disord. 2016 Feb;1(3):123-5
pubmed: 27171394
PLoS One. 2016 Dec 9;11(12):e0167463
pubmed: 27936071
Mycoses. 2014 Dec;57(12):754-8
pubmed: 25135031
Curr Pediatr Rev. 2020;16(1):33-42
pubmed: 31544694
Dermatol Ther (Heidelb). 2022 Apr;12(4):885-898
pubmed: 35262878
Infect Drug Resist. 2016 Jan 18;9:1-6
pubmed: 26848272
Chin Med. 2015 Nov 21;10:34
pubmed: 26594235
Antimicrob Agents Chemother. 2017 Jun 27;61(7):
pubmed: 28416557
Prim Care. 2015 Dec;42(4):501-16
pubmed: 26612371
Clin Dermatol. 2017 Jan - Feb;35(1):28-39
pubmed: 27938809
Int J Pharm. 2014 Sep 10;472(1-2):224-40
pubmed: 24954723
J Drugs Dermatol. 2015 Jul;14(7):686-91
pubmed: 26151784
J Pak Med Assoc. 2014 May;64(5):514-8
pubmed: 25272535
Chang Gung Med J. 2011 Jan-Feb;34(1):44-9
pubmed: 21392473
Cureus. 2021 Dec 27;13(12):e20758
pubmed: 35111444
Cutis. 2021 Sep;108(3):163-166
pubmed: 34826280
J Drugs Dermatol. 2011 Nov;10(11):1282-8
pubmed: 22052309
Mayo Clin Proc. 2022 Jul;97(7):1396-1397
pubmed: 35787867
Aust J Gen Pract. 2019 Oct;48(10):706-711
pubmed: 31569324
J Drugs Dermatol. 2015 May;14(5):492-4
pubmed: 25942668
Br J Dermatol. 2012 Nov;167(5):1076-84
pubmed: 23039091
Infection. 2021 Aug;49(4):671-676
pubmed: 33534066
J Mycol Med. 2018 Mar;28(1):101-105
pubmed: 29439839
Infect Dis Clin North Am. 2021 Mar;35(1):49-60
pubmed: 33494874
Indian Dermatol Online J. 2019 May-Jun;10(3):347-348
pubmed: 31149595
J Drugs Dermatol. 2011 Oct;10(10):1135-40
pubmed: 21968663
J Fungi (Basel). 2022 Jan 06;8(1):
pubmed: 35050000
J Drugs Dermatol. 2015 Oct;14(10 Suppl):s42-7
pubmed: 26461834
J Dtsch Dermatol Ges. 2022 Aug;20(8):1112-1121
pubmed: 35853241
Arch Dis Child Educ Pract Ed. 2015 Apr;100(2):112
pubmed: 25784752
World J Nephrol. 2016 Jul 6;5(4):372-7
pubmed: 27458566
Pediatr Dermatol. 2021 Mar;38(2):522-523
pubmed: 33320359
Mycoses. 2022 Apr;65(4):440-448
pubmed: 35102623
BMJ Mil Health. 2021 Dec;167(6):433-436
pubmed: 32205330
Mycopathologia. 2016 Dec;181(11-12):851-856
pubmed: 27435974
J Dtsch Dermatol Ges. 2021 Jul;19(7):993-1001
pubmed: 33973357
Adv Pediatr. 2007;54:241-73
pubmed: 17918474
Eur J Epidemiol. 1990 Sep;6(3):244-7
pubmed: 2253726
Expert Rev Anti Infect Ther. 2015;13(12):1433-40
pubmed: 26559086
BMC Dermatol. 2018 Jul 24;18(1):6
pubmed: 30041646
J Am Podiatr Med Assoc. 2008 Sep-Oct;98(5):353-6
pubmed: 18820036
Mycoses. 1993 Jan-Feb;36(1-2):35-41
pubmed: 8316260
Am J Manag Care. 2018 Dec;24(23 Suppl):S491-S495
pubmed: 30589248
Arch Pediatr Adolesc Med. 2002 Nov;156(11):1149-52
pubmed: 12413346
J Drugs Dermatol. 2014 Feb;13(2):162-5
pubmed: 24509966
Can J Infect Dis Med Microbiol. 2017;2017:6835725
pubmed: 28852411
Expert Opin Drug Saf. 2015 Feb;14(2):325-34
pubmed: 25409549
Pediatr Dermatol. 2022 Nov;39(6):855-865
pubmed: 36130720
J Am Acad Dermatol. 1994 Sep;31(3 Pt 2):S31-3
pubmed: 8077505
J Cutan Med Surg. 2013 Jul-Aug;17(4):243-9
pubmed: 23815956
Acta Trop. 2015 Oct;150:111-5
pubmed: 26200786
Mycoses. 2014 Sep;57(9):560-4
pubmed: 24697872
Mycoses. 2021 Oct;64(10):1140-1150
pubmed: 34145648
South Med J. 2014 Jun;107(6):374-9
pubmed: 24945173
J Eur Acad Dermatol Venereol. 2010 Sep;24(9):1099-101
pubmed: 20136678
J Dermatol. 2019 Nov;46(11):940-946
pubmed: 31436337
J Wound Care. 2017 Apr 2;26(4):179-183
pubmed: 28379097
Acta Derm Venereol. 1994 Sep;74(5):403-4
pubmed: 7817685
J R Army Med Corps. 2015 Jun;161(2):112-5
pubmed: 25091572
J Clin Microbiol. 2000 Sep;38(9):3226-30
pubmed: 10970362
Pharmaceuticals (Basel). 2022 Jun 07;15(6):
pubmed: 35745641
Int J Dermatol. 2005 Jul;44(7):590-3
pubmed: 15985032
G Ital Dermatol Venereol. 2010 Feb;145(1):1-5
pubmed: 20197740
Mycopathologia. 2013 Aug;176(1-2):83-8
pubmed: 23765324
Cochrane Database Syst Rev. 2012 Oct 17;10:CD003584
pubmed: 23076898
Front Microbiol. 2020 Apr 03;11:385
pubmed: 32308646
J Antibiot (Tokyo). 2021 Mar;74(3):206-214
pubmed: 33082529
Crit Rev Microbiol. 2015;41(3):374-88
pubmed: 24495093
Mil Med. 2018 Sep 1;183(9-10):e633-e637
pubmed: 29447400
Mycopathologia. 2017 Feb;182(1-2):67-76
pubmed: 27502504
J Pharm Pract. 2017 Dec;30(6):621-630
pubmed: 27488125
Drug Discov Ther. 2019;13(4):207-211
pubmed: 31534072
Int J Dermatol. 2017 Jan;56(1):68-74
pubmed: 27667305
Mycoses. 2023 May;66(5):448-454
pubmed: 36707404
J Mycol Med. 2020 Jun;30(2):100935
pubmed: 32139093
Recent Pat Inflamm Allergy Drug Discov. 2020;14(1):32-45
pubmed: 31738146
Dermatol Res Pract. 2010;2010:764843
pubmed: 20672004
CMAJ. 2016 Dec 6;188(17-18):E539
pubmed: 27799613
Folia Med (Plovdiv). 2021 Apr 30;63(2):292-296
pubmed: 33932023
Case Rep Dermatol. 2015 Mar 05;7(1):36-8
pubmed: 25873874
Mycoses. 2019 Nov;62(11):1084-1091
pubmed: 31444823
J Drugs Dermatol. 2016 Sep 1;15(9):1111-4
pubmed: 27602974
J Mycol Med. 2016 Dec;26(4):351-358
pubmed: 27520535
JAMA Dermatol. 2013 Mar;149(3):341-9
pubmed: 23553036
Mycoses. 2017 Jan;60(1):25-32
pubmed: 27469902
Skinmed. 2014 Mar-Apr;12(2):90-3
pubmed: 24933846
J Drugs Dermatol. 2018 Feb 1;17(2):229-232
pubmed: 29462232
Med Mycol J. 2014;55(2):E35-41
pubmed: 24943206
Clin Podiatr Med Surg. 2016 Jul;33(3):441-51
pubmed: 27215162
Mycoses. 2022 Jun;65(6):661-669
pubmed: 35466481
J Pharm Bioallied Sci. 2020 Nov;12(Suppl 2):S733-S736
pubmed: 33828369
Int J Low Extrem Wounds. 2023 Jun;22(2):321-327
pubmed: 33891512
An Bras Dermatol. 2014 Mar-Apr;89(2):259-64
pubmed: 24770502
J Clin Aesthet Dermatol. 2014 Oct;7(10):20-7
pubmed: 25371767
Int J Dermatol. 2015 Feb;54(2):146-9
pubmed: 24739076
J Fungi (Basel). 2022 Mar 29;8(4):
pubmed: 35448582
Indian J Dermatol. 2014 May;59(3):262-7
pubmed: 24891657
Semin Cutan Med Surg. 2016 Jun;35(6 Suppl):S110-3
pubmed: 27537822
Core Evid. 2014 Sep 24;9:113-24
pubmed: 25285056
Med Mycol. 2020 Apr 1;58(3):401-403
pubmed: 31111903
Mycoses. 2022 Jul;65(7):741-746
pubmed: 35535729
APMIS. 2023 Jan 16;:
pubmed: 36645313
Indian Dermatol Online J. 2016 Mar-Apr;7(2):77-86
pubmed: 27057486
J Drugs Dermatol. 2014 Jul;13(7):838-46
pubmed: 25007368
J R Army Med Corps. 2017 Feb;163(1):27-30
pubmed: 26746996
J Med Microbiol. 2021 Mar;70(3):
pubmed: 33533707
Clin Dermatol. 2014 Sep-Oct;32(5):621-7
pubmed: 25160103
Med Mycol J. 2019;60(4):91-94
pubmed: 31787732
J Drugs Dermatol. 2014 Jul;13(7):803-8
pubmed: 25007362
J Am Podiatr Med Assoc. 2015 Mar;105(2):121-4
pubmed: 25815650
Mycopathologia. 2021 Aug;186(4):565-567
pubmed: 34224077
BMC Microbiol. 2020 Sep 10;20(1):276
pubmed: 32912139
J Eur Acad Dermatol Venereol. 2006 Feb;20(2):158-65
pubmed: 16441623
J Am Board Fam Med. 2022 Mar-Apr;35(2):435-442
pubmed: 35379733
J Dermatol. 2021 Apr;48(4):564-567
pubmed: 33439506